marketcap
Facebook
Twitter
Telegram
Report an ErrorAntares Pharma, Inc. Financial Ratios 2011-2024 | ATRS
Annual Financial Ratios Antares Pharma, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E |
12.9 | -379.0 | -74.8 | -21.1 | -14.0 | -8.7 | -8.7 | -29.5 | -36.6 | -55.0 |
P/S |
4.9 | 6.2 | 7.7 | 6.5 | 6.5 | 3.9 | 11.5 | 29.3 | 18.5 | 14.7 |
EV/EBITDA |
44.0 | 221.3 | -34.9 | -24.5 | -14.1 | -7.8 | -8.0 | -27.8 | -32.7 | -52.0 |
PEG |
0.0 | -5.05 | -1.17 | -0.67 | 0.98 | -0.18 | 0.13 | 0.49 | 0.37 | -1.93 |
P/B |
6.1 | 14.1 | 12.5 | 10.5 | 7.5 | 2.7 | 7.4 | 8.5 | 4.8 | 7.8 |
P/CF |
108.5 | -59.3 | -26.7 | -14.5 | -16.9 | -5.2 | -9.6 | -33.3 | -30.0 | -96.3 |
ROE % |
47.18 | -3.72 | -16.70 | -49.91 | -53.82 | -30.81 | -85.33 | -29.00 | -13.20 | -14.09 |
ROA % |
26.44 | -1.53 | -7.38 | -22.52 | -36.70 | -24.43 | -51.11 | -23.06 | -11.96 | -10.46 |
ROCE % |
9.12 | 0.99 | -27.18 | -28.07 | -51.95 | -30.21 | -78.83 | -28.73 | -13.07 | -13.88 |
DSO |
122.9 | 127.6 | 169.0 | 79.5 | 63.4 | 63.6 | 48.3 | 18.3 | 36.0 | 56.2 |
DIO |
105.4 | 115.7 | 133.4 | 123.3 | 67.5 | 107.4 | 190.3 | 256.4 | 38.4 | 47.9 |
DPO |
93.7 | 93.3 | 130.8 | 79.2 | 99.9 | 97.3 | 327.2 | 253.1 | 109.8 | 114.9 |
All numbers in USD currency